ECS

Contamination Control Strategy (CCS) for Pharmaceutical Industry

Contamination Control Strategy (CCS) for Pharmaceutical Industry

Defining a well-documented cross-contamination strategy involves several key steps. When defining a CCS (contamination control strategy), it is recommended to consider not only cross-contamination but also all other types of contaminants. While the majority of available guidance (e.g ECS, PDA, Annex-1 of EU GMP) primarily focuses on parenteral preparation, it ... Read More